Latest filing published 26 Jul 2023 for GreenLight Biosciences Holdings, PBC, €83k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Charles L. Cooney, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Genzyme Corp, Polypore International, Inc. and GreenLight Biosciences Holdings, PBC. In total, 37 filings cover trades dated from 27 July 2006 to 24 July 2023.
On the market, this insider has only sold: 7 sales, €2.8M in total. Outside the open market, there are 10 share grants and 10 option exercises.
The newest entry dates from 26 July 2023: a transaction of €83k, in GreenLight Biosciences Holdings, PBC. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations